Atlas Trials

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Clinical trial NCT03416153 · COMPLETED

Trial details

NCT number
NCT03416153
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharynx Cancer
Start date
2018-05-21
Primary completion
2023-05-05
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.